Article(id=1330233692263396135, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233670775976505, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2024.02.006, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1686931200000, receivedDateStr=2023-06-17, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795082026781, onlineDateStr=2026-11-19, pubDate=1707494400000, pubDateStr=2024-02-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795082026781, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795082026781, creator=13701087609, updateTime=1795082026781, updator=13701087609, issue=Issue{id=1330233670775976505, tenantId=1146029695717560320, journalId=1319690259887390882, year='2024', volume='55', issue='2', pageStart='165', pageEnd='308', issueExtLink='null', onlineDate='null', pubDate='1707494400000', pubDateStr='2024-02-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795082021659, creator='13701087609', updateTime=1795082707094, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330236546143334510, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233670775976505, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330236546143334511, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233670775976505, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=210, endPage=216, ext={EN=ArticleExt(id=1330233692443751208, articleId=1330233692263396135, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Exploring the Key Points of Technology Transfer for Production Process of Biological Macromolecules, columnId=1327671134809600231, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Technology transfer is crucial throughout the entire lifecycle of biological macromolecules. Given the intricate structure and the unpredictable production of biological macromolecules, this review categorizes the technology transfer of production process of biological macromolecules into two phases: preclinical and early clinical sample production, as well as pivotal clinical and commercialization stage sample production. Depending on the objectives and tasks of each phase, key control points for technology transfer in production processes, encompassing cell lines, raw materials, production processes, safety evaluation of exogenous factors, and comparability studies, are identified. And the corresponding technology transfer strategies are suggested, accompanied by a compilation of common challenges faced during the technology transfer process of biological macromolecules, with the aim to serve as a guide for biopharmaceutical companies in their technology transfer for production process.

, authors=Baoqing FAN, Zhenyu WANG*, authorsList=Baoqing FAN, Zhenyu WANG, authorCompany=null, correspAuthors=Zhenyu WANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330233692712186665, articleId=1330233692263396135, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=生物大分子药物生产工艺技术转移关键点探讨, columnId=1327671135019315436, journalTitle=中国医药工业杂志, columnName=综述, runingTitle=null, highlight=null, articleAbstract=

技术转移贯穿于生物大分子药物的整个生命周期。考虑到生物大分子药物结构的复杂性及生产的不可控性,该文将生物大分子药物的生产工艺技术转移分为临床前和早期临床样品生产,以及关键性临床和商业化阶段样品生产2个阶段,分别进行探讨。根据每个阶段的目标任务,从细胞株、原材料、生产工艺、外源因子安全性评价以及可比性研究等方面细化生产工艺技术转移的关键控制点,据此提出相对应的技术转移策略,并列举了生物大分子药物技术转移过程当中经常遇到的问题,以期为生物制药企业进行生产工艺技术转移提供参考。

, authors=范宝庆, 王振玉*, authorsList=范宝庆, 王振玉, authorCompany=null, correspAuthors=王振玉, authorNote=

范宝庆(1982—),男,高级工程师,从事大分子生物药的下游分离纯化研究。

, correspAuthorsNote=
王振玉(1986—),男,博士,从事大分子生物药研发与CMC。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=EZCvPfHsehi98pcURHNW1A==, magXml=7FiiOHIbNzW2yD5xQBCp7g==, pdfUrl=null, pdf=EqqaegwoI4BFN3/UqfTR2w==, pdfFileSize=1662146, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=7OFhJzed+XMxSclppfC08Q==, mapNumber=null, fund=null)}, authors=[Author(id=1330233692984816431, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233693060313905, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, authorId=1330233692984816431, language=EN, stringName=Baoqing FAN, firstName=Baoqing, middleName=null, lastName=FAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Jecho (Tianjin) BioPharmaceuticals Co., Ltd., Tianjin 300480, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233693135811378, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, authorId=1330233692984816431, language=CN, stringName=范宝庆, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=杰科(天津)生物医药有限公司,天津 300480, bio={"content":"

范宝庆(1982—),男,高级工程师,从事大分子生物药的下游分离纯化研究。

"}, bioImg=null, bioContent=

范宝庆(1982—),男,高级工程师,从事大分子生物药的下游分离纯化研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233692900930347, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, xref=null, ext=[AuthorCompanyExt(id=1330233692909318956, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, companyId=1330233692900930347, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Jecho (Tianjin) BioPharmaceuticals Co., Ltd., Tianjin 300480), AuthorCompanyExt(id=1330233692917707565, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, companyId=1330233692900930347, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=杰科(天津)生物医药有限公司,天津 300480)])]), Author(id=1330233693198725940, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zhenyu.wang@jeohobio.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330233693278417718, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, authorId=1330233693198725940, language=EN, stringName=Zhenyu WANG, firstName=Zhenyu, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Jecho (Tianjin) BioPharmaceuticals Co., Ltd., Tianjin 300480, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233693332943671, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, authorId=1330233693198725940, language=CN, stringName=王振玉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=杰科(天津)生物医药有限公司,天津 300480, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233692900930347, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, xref=null, ext=[AuthorCompanyExt(id=1330233692909318956, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, companyId=1330233692900930347, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Jecho (Tianjin) BioPharmaceuticals Co., Ltd., Tianjin 300480), AuthorCompanyExt(id=1330233692917707565, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, companyId=1330233692900930347, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=杰科(天津)生物医药有限公司,天津 300480)])])], keywords=[Keyword(id=1330233693421024056, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, language=EN, orderNo=1, keyword=biological macromolecule), Keyword(id=1330233693488132921, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, language=EN, orderNo=2, keyword=production process), Keyword(id=1330233693546853178, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, language=EN, orderNo=3, keyword=technology transfer), Keyword(id=1330233693634933563, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, language=EN, orderNo=4, keyword=key control point), Keyword(id=1330233693710431036, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, language=CN, orderNo=1, keyword=生物大分子药物), Keyword(id=1330233693773345597, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, language=CN, orderNo=2, keyword=生产工艺), Keyword(id=1330233693853037374, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, language=CN, orderNo=3, keyword=技术转移), Keyword(id=1330233693928534847, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, language=CN, orderNo=4, keyword=关键控制点)], refs=[Reference(id=1330233694029198144, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=李力,丁满生,路慧丽,等.基于风险评估的技术转移及其管理[J].中国医药工业杂志,2020,51(6):795-800., articleTitle=null, refAbstract=null), Reference(id=1330233694100501313, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=徐霆.生物大分子药物的研究现状与展望[J].药学进展,2018,42(6):433-434., articleTitle=null, refAbstract=null), Reference(id=1330233694175998786, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=郑淑贞,周逢云,代虎,等.抗CD20单克隆抗体药物的研发进展[J].中国医药工业杂志,2021,52(11):1452-1459., articleTitle=null, refAbstract=null), Reference(id=1330233694234719043, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=WU T, ZHU J W.Recent development and optimization of pseudomonas aeruginosa exotoxin immunotoxins in cancer therapeutic applications [J].Int Immunopharmacol, 2021, 96(27): 107759., articleTitle=null, refAbstract=null), Reference(id=1330233694306022212, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=李青,毋立华,葛渊源,等.药品生产技术转移法规要求、常见问题与监管考量[J].中国医药工业杂志,2022,53(4):572-577., articleTitle=null, refAbstract=null), Reference(id=1330233694381519685, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=国家食品药品监督管理局药品审评中心.临床试验期间生物制品药学研究和变更技术指导原则(征求意见稿)[EB/OL].(2020-09-10)[2023-04-16].https://www.cde.org.cn/main/news/viewInfoCommon/3e7f133e8a854894fafa49752d7d8a9e., articleTitle=null, refAbstract=null), Reference(id=1330233694444434246, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=赵梦琳,刘继东,朱祥平,等.CHO-S高产量细胞株的新型构建方法及其评价[J].中国医药工业杂志,2019,50(2):194-199., articleTitle=null, refAbstract=null), Reference(id=1330233694511543111, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=朱向阳.抗体药物工艺开发需要考虑的因素[J].中国新药杂志,2015,24(20):2363-2368., articleTitle=null, refAbstract=null), Reference(id=1330233696122155848, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=杨雅静,路慧丽,朱建伟.GMP环境下基于风险的供应商现场审计[J].中国医药工业杂志,2016,47(2):241-245., articleTitle=null, refAbstract=null), Reference(id=1330233696189264713, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=宋丽娜,崔靖,何伍.创新单抗药物申报临床阶段药学研究关注点[J].中国临床药理学杂志,2021,37(10):1301-1304., articleTitle=null, refAbstract=null), Reference(id=1330233696260567882, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=王霞,陈恒青,朱建伟.质量管理体系中实施质量量度对制药工业的意义[J].中国医药工业杂志,2020,51(4):545-550., articleTitle=null, refAbstract=null), Reference(id=1330233696319288139, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=李敏,郭秀侠.关于生物制品工艺验证的审评实践与思考[J].中国生物制品学杂志,2017,30(6):664-668., articleTitle=null, refAbstract=null), Reference(id=1330233696382202700, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=周莉婷,罗建辉.生物制品上市申请药学申报资料常见问题和审评关注要点分析[J].中国新药杂志,2020,29(3):264-268., articleTitle=null, refAbstract=null), Reference(id=1330233696466088781, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHU J W.Update on production of recombinant therapeutic protein: transient gene expression [M].Shropshire: Smithers Rapra Technology, 2013: 135-158., articleTitle=null, refAbstract=null), Reference(id=1330233696529003342, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=WU T, SONG Z Y, HUANG H Q, et al.Construction and evaluation of GPC3-targeted immunotoxins as a novel therapeutic modality for hepatocellular carcinoma [J].Int Immunopharmacol, 2022, 113(Pt B): 109393., articleTitle=null, refAbstract=null), Reference(id=1330233696596112207, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=许丹,周艳,段爽,等.探讨单抗注册生产现场检查中的质量控制要点[J].中国药事,2020,34(10):1115-1123., articleTitle=null, refAbstract=null), Reference(id=1330233696667415376, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=王云,朱建伟.化学合成原料药起始物料的选择原则[J].中国医药工业杂,2022,53(5):728-734., articleTitle=null, refAbstract=null), Reference(id=1330233696726135633, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=仇宇星,雷清.病毒样颗粒及其在疫苗中的应用[J].微生物学免疫学进展,2022,50(6):73-79., articleTitle=null, refAbstract=null), Reference(id=1330233696805827410, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=代虎,丁满生,朱建伟.制药行业基于风险管理的变更控制[J].中国医药工业杂志,2020,51(3):416-420., articleTitle=null, refAbstract=null), Reference(id=1330233696893907795, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=金苏,李敏.浅析国内外药品临床试验期间药学变更的监管及技术评价考虑[J].中国生物制品学杂志,2019,32(2):243-248., articleTitle=null, refAbstract=null), Reference(id=1330233696965210964, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA.Lucentis: EPAR Scientific discussion [R/OL].(2007-03-14)[2023-04-16].https://www.ema.europa.eu/en/documents/scientific-discussion/lucentis-epar-scientific-discussion_en.pdf., articleTitle=null, refAbstract=null), Reference(id=1330233697028125525, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=袁利佳,汪小燕,王佳,等.关联审评政策下药用辅料与药包材变更管理的思考[J].中国药事,2022,36(2):121-127., articleTitle=null, refAbstract=null), Reference(id=1330233697091040086, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=平玲,牛杰,张铭润,等.Sabin株脊髓灰质炎灭活疫苗与不同包材的相容性[J].中国生物制品学杂志,2021,34(7):775-781., articleTitle=null, refAbstract=null), Reference(id=1330233697149760343, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=徐隆昌,崔靖,韦薇.新兴治疗产品外源因子安全性研究与评价的一般考虑[J].中国新药杂志,2022,31(11):1052-1056., articleTitle=null, refAbstract=null), Reference(id=1330233697212674904, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=赛文博,于鹏丽,李小静,等.重组表达生物制品生产中病毒清除验证策略研究进展[J].中国新药杂志,2021,30(10):876-879., articleTitle=null, refAbstract=null), Reference(id=1330233697275589465, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG Y C, ZHENG C, ZHUANG C, et al.Characterization and pre-clinical assessment of a proposed biosimilar to its originator Omalizumab [J].Eur J Pharm Sci, 2022, 11(1): 106292., articleTitle=null, refAbstract=null), Reference(id=1330233697346892634, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=刘伯宁,罗建辉.关于创新型抗体药物药学评价的思考[J].药学学报,2017,52(12):1811-1819., articleTitle=null, refAbstract=null), Reference(id=1330233697414001499, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=陈颖,王广平,易八贤.我国药品审评审批制度改革对创新药技术转移的影响[J].中国医药工业杂志,2017,48(7):1083-1091, articleTitle=null, refAbstract=null), Reference(id=1330233697481110364, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=杜婧,高胜男.药品注册核查中对技术转移方面的探讨[J].中国新药杂志,2022,31(17):1684-1688., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330233692900930347, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, xref=null, ext=[AuthorCompanyExt(id=1330233692909318956, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, companyId=1330233692900930347, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Jecho (Tianjin) BioPharmaceuticals Co., Ltd., Tianjin 300480), AuthorCompanyExt(id=1330233692917707565, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, companyId=1330233692900930347, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=杰科(天津)生物医药有限公司,天津 300480)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.02.006, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2024.02.006, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2024.02.006, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2024.02.006, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1707494400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
生物大分子药物生产工艺技术转移关键点探讨
范宝庆 , 王振玉 *
中国医药工业杂志 | 综述 2024,55(2): 210-216
收起
收藏切换
中国医药工业杂志 |综述 2024 , 55 (2) : 210 -216
生物大分子药物生产工艺技术转移关键点探讨
全屏
[Author(id=1330233692984816431, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233693060313905, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, authorId=1330233692984816431, language=EN, stringName=Baoqing FAN, firstName=Baoqing, middleName=null, lastName=FAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Jecho (Tianjin) BioPharmaceuticals Co., Ltd., Tianjin 300480, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233693135811378, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, authorId=1330233692984816431, language=CN, stringName=范宝庆, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=杰科(天津)生物医药有限公司,天津 300480, bio={"content":"

范宝庆(1982—),男,高级工程师,从事大分子生物药的下游分离纯化研究。

"}, bioImg=null, bioContent=

范宝庆(1982—),男,高级工程师,从事大分子生物药的下游分离纯化研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233692900930347, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, xref=null, ext=[AuthorCompanyExt(id=1330233692909318956, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, companyId=1330233692900930347, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Jecho (Tianjin) BioPharmaceuticals Co., Ltd., Tianjin 300480), AuthorCompanyExt(id=1330233692917707565, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, companyId=1330233692900930347, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=杰科(天津)生物医药有限公司,天津 300480)])]), Author(id=1330233693198725940, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zhenyu.wang@jeohobio.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330233693278417718, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, authorId=1330233693198725940, language=EN, stringName=Zhenyu WANG, firstName=Zhenyu, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Jecho (Tianjin) BioPharmaceuticals Co., Ltd., Tianjin 300480, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233693332943671, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, authorId=1330233693198725940, language=CN, stringName=王振玉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=杰科(天津)生物医药有限公司,天津 300480, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233692900930347, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, xref=null, ext=[AuthorCompanyExt(id=1330233692909318956, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, companyId=1330233692900930347, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Jecho (Tianjin) BioPharmaceuticals Co., Ltd., Tianjin 300480), AuthorCompanyExt(id=1330233692917707565, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233692263396135, companyId=1330233692900930347, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=杰科(天津)生物医药有限公司,天津 300480)])])]
范宝庆, 王振玉*
作者信息
  • 杰科(天津)生物医药有限公司,天津 300480
通讯作者:
王振玉(1986—),男,博士,从事大分子生物药研发与CMC。E-mail:
作者简介:

范宝庆(1982—),男,高级工程师,从事大分子生物药的下游分离纯化研究。

Exploring the Key Points of Technology Transfer for Production Process of Biological Macromolecules
Baoqing FAN, Zhenyu WANG*
Affiliations
  • Jecho (Tianjin) BioPharmaceuticals Co., Ltd., Tianjin 300480
出版时间: 2024-02-10 doi: 10.16522/j.cnki.cjph.2024.02.006
文章导航
收藏切换

技术转移贯穿于生物大分子药物的整个生命周期。考虑到生物大分子药物结构的复杂性及生产的不可控性,该文将生物大分子药物的生产工艺技术转移分为临床前和早期临床样品生产,以及关键性临床和商业化阶段样品生产2个阶段,分别进行探讨。根据每个阶段的目标任务,从细胞株、原材料、生产工艺、外源因子安全性评价以及可比性研究等方面细化生产工艺技术转移的关键控制点,据此提出相对应的技术转移策略,并列举了生物大分子药物技术转移过程当中经常遇到的问题,以期为生物制药企业进行生产工艺技术转移提供参考。

生物大分子药物  /  生产工艺  /  技术转移  /  关键控制点

Technology transfer is crucial throughout the entire lifecycle of biological macromolecules. Given the intricate structure and the unpredictable production of biological macromolecules, this review categorizes the technology transfer of production process of biological macromolecules into two phases: preclinical and early clinical sample production, as well as pivotal clinical and commercialization stage sample production. Depending on the objectives and tasks of each phase, key control points for technology transfer in production processes, encompassing cell lines, raw materials, production processes, safety evaluation of exogenous factors, and comparability studies, are identified. And the corresponding technology transfer strategies are suggested, accompanied by a compilation of common challenges faced during the technology transfer process of biological macromolecules, with the aim to serve as a guide for biopharmaceutical companies in their technology transfer for production process.

biological macromolecule  /  production process  /  technology transfer  /  key control point
范宝庆, 王振玉. 生物大分子药物生产工艺技术转移关键点探讨. 中国医药工业杂志, 2024 , 55 (2) : 210 -216 . DOI: 10.16522/j.cnki.cjph.2024.02.006
Baoqing FAN, Zhenyu WANG. Exploring the Key Points of Technology Transfer for Production Process of Biological Macromolecules[J]. Chinese Journal of Pharmaceuticals, 2024 , 55 (2) : 210 -216 . DOI: 10.16522/j.cnki.cjph.2024.02.006

参考文献 引证文献
排序方式:
[1]
李力,丁满生,路慧丽,等.基于风险评估的技术转移及其管理[J].中国医药工业杂志,2020,51(6):795-800.
[2]
徐霆.生物大分子药物的研究现状与展望[J].药学进展,2018,42(6):433-434.
[3]
郑淑贞,周逢云,代虎,等.抗CD20单克隆抗体药物的研发进展[J].中国医药工业杂志,2021,52(11):1452-1459.
[4]
WU T, ZHU J W.Recent development and optimization of pseudomonas aeruginosa exotoxin immunotoxins in cancer therapeutic applications [J].Int Immunopharmacol, 2021, 96(27): 107759.
[5]
李青,毋立华,葛渊源,等.药品生产技术转移法规要求、常见问题与监管考量[J].中国医药工业杂志,2022,53(4):572-577.
[6]
国家食品药品监督管理局药品审评中心.临床试验期间生物制品药学研究和变更技术指导原则(征求意见稿)[EB/OL].(2020-09-10)[2023-04-16].https://www.cde.org.cn/main/news/viewInfoCommon/3e7f133e8a854894fafa49752d7d8a9e.
[7]
赵梦琳,刘继东,朱祥平,等.CHO-S高产量细胞株的新型构建方法及其评价[J].中国医药工业杂志,2019,50(2):194-199.
[8]
朱向阳.抗体药物工艺开发需要考虑的因素[J].中国新药杂志,2015,24(20):2363-2368.
[9]
杨雅静,路慧丽,朱建伟.GMP环境下基于风险的供应商现场审计[J].中国医药工业杂志,2016,47(2):241-245.
[10]
宋丽娜,崔靖,何伍.创新单抗药物申报临床阶段药学研究关注点[J].中国临床药理学杂志,2021,37(10):1301-1304.
[11]
王霞,陈恒青,朱建伟.质量管理体系中实施质量量度对制药工业的意义[J].中国医药工业杂志,2020,51(4):545-550.
[12]
李敏,郭秀侠.关于生物制品工艺验证的审评实践与思考[J].中国生物制品学杂志,2017,30(6):664-668.
[13]
周莉婷,罗建辉.生物制品上市申请药学申报资料常见问题和审评关注要点分析[J].中国新药杂志,2020,29(3):264-268.
[14]
ZHU J W.Update on production of recombinant therapeutic protein: transient gene expression [M].Shropshire: Smithers Rapra Technology, 2013: 135-158.
[15]
WU T, SONG Z Y, HUANG H Q, et al.Construction and evaluation of GPC3-targeted immunotoxins as a novel therapeutic modality for hepatocellular carcinoma [J].Int Immunopharmacol, 2022, 113(Pt B): 109393.
[16]
许丹,周艳,段爽,等.探讨单抗注册生产现场检查中的质量控制要点[J].中国药事,2020,34(10):1115-1123.
[17]
王云,朱建伟.化学合成原料药起始物料的选择原则[J].中国医药工业杂,2022,53(5):728-734.
[18]
仇宇星,雷清.病毒样颗粒及其在疫苗中的应用[J].微生物学免疫学进展,2022,50(6):73-79.
[19]
代虎,丁满生,朱建伟.制药行业基于风险管理的变更控制[J].中国医药工业杂志,2020,51(3):416-420.
[20]
金苏,李敏.浅析国内外药品临床试验期间药学变更的监管及技术评价考虑[J].中国生物制品学杂志,2019,32(2):243-248.
[21]
EMA.Lucentis: EPAR Scientific discussion [R/OL].(2007-03-14)[2023-04-16].https://www.ema.europa.eu/en/documents/scientific-discussion/lucentis-epar-scientific-discussion_en.pdf.
[22]
袁利佳,汪小燕,王佳,等.关联审评政策下药用辅料与药包材变更管理的思考[J].中国药事,2022,36(2):121-127.
[23]
平玲,牛杰,张铭润,等.Sabin株脊髓灰质炎灭活疫苗与不同包材的相容性[J].中国生物制品学杂志,2021,34(7):775-781.
[24]
徐隆昌,崔靖,韦薇.新兴治疗产品外源因子安全性研究与评价的一般考虑[J].中国新药杂志,2022,31(11):1052-1056.
[25]
赛文博,于鹏丽,李小静,等.重组表达生物制品生产中病毒清除验证策略研究进展[J].中国新药杂志,2021,30(10):876-879.
[26]
WANG Y C, ZHENG C, ZHUANG C, et al.Characterization and pre-clinical assessment of a proposed biosimilar to its originator Omalizumab [J].Eur J Pharm Sci, 2022, 11(1): 106292.
[27]
刘伯宁,罗建辉.关于创新型抗体药物药学评价的思考[J].药学学报,2017,52(12):1811-1819.
[28]
陈颖,王广平,易八贤.我国药品审评审批制度改革对创新药技术转移的影响[J].中国医药工业杂志,2017,48(7):1083-1091
[29]
杜婧,高胜男.药品注册核查中对技术转移方面的探讨[J].中国新药杂志,2022,31(17):1684-1688.
2024年第55卷第2期
31
8
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2024.02.006
  • 接收时间:2023-06-17
  • 首发时间:2026-11-19
  • 出版时间:2024-02-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-06-17
基金
作者信息
    杰科(天津)生物医药有限公司,天津 300480

通讯作者:

王振玉(1986—),男,博士,从事大分子生物药研发与CMC。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.02.006
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏